Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-26 @ 3:15 AM
Study NCT ID:
NCT01473420
Status:
COMPLETED
Last Update Posted:
2018-08-09
First Post:
2011-11-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2014-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-02
First Submit QC Date:
None
Study First Post Date:
2011-11-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-16
Results First Submit QC Date:
None
Results First Post Date:
2018-06-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-03-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-07-12
Last Update Post Date:
2018-08-09
Last Update Post Date Type:
ACTUAL